CLIN ENDOCRINOL 润色咨询

CLINICAL ENDOCRINOLOGY

出版年份:1972 年文章数:4775 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:4.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2115113, encodeId=ceb92115113fa, content=投稿两个多月了,现在还是Under Review,催了一次编辑说是还在找审稿人,审稿有点慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/2b20a1e314924e5396c0110729210109/544383ced8934545a4b92896a7ffeef1.jpg, createdBy=b6715568846, createdName=Iam雨后彩虹, createdTime=Fri Feb 17 16:10:56 CST 2023, time=2023-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179873, encodeId=1f3611e9873a8, content=请问一下各位大佬,该杂志需要版面费吗,case report and review接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ca66444402, createdName=ms5000001652603950, createdTime=Sun Jan 02 22:47:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501260, encodeId=93da50126070, content=请问楼下的这个杂志在线投稿时,第4项是推荐reviewer,而且还是必须要填的,不然无法成功投稿,从哪里能找到他们的reviewer啊?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 21 23:01:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105791, encodeId=1a3d2105e9156, content=请问首次投稿的时候就得把原始数据放在共享数据库里吗,能不能等看看会不会直接拒稿再进行下一步共享数据?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Dec 12 21:53:04 CST 2022, time=2022-12-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210105, encodeId=f67c12101054d, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:内分泌<br>经验分享:不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29b1939503, createdName=Wittyone, createdTime=Sun Apr 10 19:28:15 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559798, encodeId=50cf559e9840, content=Under review 下一个是什么 大概多久呀<span class="quote">151****6521暂无昵称 2018-06-04 发表::<br>投稿第二天就Under review了,听说这个杂志没有with editor这个状态</span><span class="quote">151****6521暂无昵称 2018-06-04 13:56:00 发表:<br>投稿第二天就Under review了,听说这个杂志没有with editor这个状态</span>, beContent=151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了,听说这个杂志没有with editor这个状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e2398662, createdName=1234c804m77暂无昵称, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581170, encodeId=a8b45811e0f9, content=都说不收糖尿病的了<span class="quote">hpchensd 2019-11-21 00:00:00 发表:<br>啥原因?我也想投一篇糖尿病高血压的</span>, beContent=hpchensd 2019-11-21 00:00:00 发表: 啥原因?我也想投一篇糖尿病高血压的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/01/768c3273b4a500f3bc36c611fc31585d.jpg, createdBy=3f032574018, createdName=Allianst, createdTime=Mon Dec 09 00:00:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052346, encodeId=4b6c10523465b, content=偏重的研究方向:内分泌<br>经验分享:2021.09.16投稿,2021.09.17让修稿,但是审稿意见就说了下如果是随机对照实验的话,请遵循对照原则(我的不是),然后提了下文章格式让弄成双倍间隔,就没有了。感觉好危险,这怎么修啊,你们的会给你发修改稿吗,上面会标注细节的那种?第一次投稿的小白,希望同道回答下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Fri Sep 17 16:29:14 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198382, encodeId=8573119838230, content=这杂志对国人友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc31688675, createdName=Labmed 9954, createdTime=Tue Mar 01 15:16:11 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088823, encodeId=54391088823f6, content=如何查找特定期刊要求的格式?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2023-02-17 Iam雨后彩虹 来自上海

    投稿两个多月了,现在还是Under Review,催了一次编辑说是还在找审稿人,审稿有点慢啊……

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2115113, encodeId=ceb92115113fa, content=投稿两个多月了,现在还是Under Review,催了一次编辑说是还在找审稿人,审稿有点慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/2b20a1e314924e5396c0110729210109/544383ced8934545a4b92896a7ffeef1.jpg, createdBy=b6715568846, createdName=Iam雨后彩虹, createdTime=Fri Feb 17 16:10:56 CST 2023, time=2023-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179873, encodeId=1f3611e9873a8, content=请问一下各位大佬,该杂志需要版面费吗,case report and review接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ca66444402, createdName=ms5000001652603950, createdTime=Sun Jan 02 22:47:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501260, encodeId=93da50126070, content=请问楼下的这个杂志在线投稿时,第4项是推荐reviewer,而且还是必须要填的,不然无法成功投稿,从哪里能找到他们的reviewer啊?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 21 23:01:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105791, encodeId=1a3d2105e9156, content=请问首次投稿的时候就得把原始数据放在共享数据库里吗,能不能等看看会不会直接拒稿再进行下一步共享数据?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Dec 12 21:53:04 CST 2022, time=2022-12-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210105, encodeId=f67c12101054d, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:内分泌<br>经验分享:不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29b1939503, createdName=Wittyone, createdTime=Sun Apr 10 19:28:15 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559798, encodeId=50cf559e9840, content=Under review 下一个是什么 大概多久呀<span class="quote">151****6521暂无昵称 2018-06-04 发表::<br>投稿第二天就Under review了,听说这个杂志没有with editor这个状态</span><span class="quote">151****6521暂无昵称 2018-06-04 13:56:00 发表:<br>投稿第二天就Under review了,听说这个杂志没有with editor这个状态</span>, beContent=151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了,听说这个杂志没有with editor这个状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e2398662, createdName=1234c804m77暂无昵称, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581170, encodeId=a8b45811e0f9, content=都说不收糖尿病的了<span class="quote">hpchensd 2019-11-21 00:00:00 发表:<br>啥原因?我也想投一篇糖尿病高血压的</span>, beContent=hpchensd 2019-11-21 00:00:00 发表: 啥原因?我也想投一篇糖尿病高血压的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/01/768c3273b4a500f3bc36c611fc31585d.jpg, createdBy=3f032574018, createdName=Allianst, createdTime=Mon Dec 09 00:00:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052346, encodeId=4b6c10523465b, content=偏重的研究方向:内分泌<br>经验分享:2021.09.16投稿,2021.09.17让修稿,但是审稿意见就说了下如果是随机对照实验的话,请遵循对照原则(我的不是),然后提了下文章格式让弄成双倍间隔,就没有了。感觉好危险,这怎么修啊,你们的会给你发修改稿吗,上面会标注细节的那种?第一次投稿的小白,希望同道回答下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Fri Sep 17 16:29:14 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198382, encodeId=8573119838230, content=这杂志对国人友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc31688675, createdName=Labmed 9954, createdTime=Tue Mar 01 15:16:11 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088823, encodeId=54391088823f6, content=如何查找特定期刊要求的格式?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-01-02 ms5000001652603950

    请问一下各位大佬,该杂志需要版面费吗,case report and review接收吗

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2115113, encodeId=ceb92115113fa, content=投稿两个多月了,现在还是Under Review,催了一次编辑说是还在找审稿人,审稿有点慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/2b20a1e314924e5396c0110729210109/544383ced8934545a4b92896a7ffeef1.jpg, createdBy=b6715568846, createdName=Iam雨后彩虹, createdTime=Fri Feb 17 16:10:56 CST 2023, time=2023-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179873, encodeId=1f3611e9873a8, content=请问一下各位大佬,该杂志需要版面费吗,case report and review接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ca66444402, createdName=ms5000001652603950, createdTime=Sun Jan 02 22:47:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501260, encodeId=93da50126070, content=请问楼下的这个杂志在线投稿时,第4项是推荐reviewer,而且还是必须要填的,不然无法成功投稿,从哪里能找到他们的reviewer啊?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 21 23:01:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105791, encodeId=1a3d2105e9156, content=请问首次投稿的时候就得把原始数据放在共享数据库里吗,能不能等看看会不会直接拒稿再进行下一步共享数据?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Dec 12 21:53:04 CST 2022, time=2022-12-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210105, encodeId=f67c12101054d, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:内分泌<br>经验分享:不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29b1939503, createdName=Wittyone, createdTime=Sun Apr 10 19:28:15 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559798, encodeId=50cf559e9840, content=Under review 下一个是什么 大概多久呀<span class="quote">151****6521暂无昵称 2018-06-04 发表::<br>投稿第二天就Under review了,听说这个杂志没有with editor这个状态</span><span class="quote">151****6521暂无昵称 2018-06-04 13:56:00 发表:<br>投稿第二天就Under review了,听说这个杂志没有with editor这个状态</span>, beContent=151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了,听说这个杂志没有with editor这个状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e2398662, createdName=1234c804m77暂无昵称, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581170, encodeId=a8b45811e0f9, content=都说不收糖尿病的了<span class="quote">hpchensd 2019-11-21 00:00:00 发表:<br>啥原因?我也想投一篇糖尿病高血压的</span>, beContent=hpchensd 2019-11-21 00:00:00 发表: 啥原因?我也想投一篇糖尿病高血压的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/01/768c3273b4a500f3bc36c611fc31585d.jpg, createdBy=3f032574018, createdName=Allianst, createdTime=Mon Dec 09 00:00:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052346, encodeId=4b6c10523465b, content=偏重的研究方向:内分泌<br>经验分享:2021.09.16投稿,2021.09.17让修稿,但是审稿意见就说了下如果是随机对照实验的话,请遵循对照原则(我的不是),然后提了下文章格式让弄成双倍间隔,就没有了。感觉好危险,这怎么修啊,你们的会给你发修改稿吗,上面会标注细节的那种?第一次投稿的小白,希望同道回答下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Fri Sep 17 16:29:14 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198382, encodeId=8573119838230, content=这杂志对国人友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc31688675, createdName=Labmed 9954, createdTime=Tue Mar 01 15:16:11 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088823, encodeId=54391088823f6, content=如何查找特定期刊要求的格式?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2014-02-21 匿名用户

    请问楼下的这个杂志在线投稿时,第4项是推荐reviewer,而且还是必须要填的,不然无法成功投稿,从哪里能找到他们的reviewer啊?谢谢

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2115113, encodeId=ceb92115113fa, content=投稿两个多月了,现在还是Under Review,催了一次编辑说是还在找审稿人,审稿有点慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/2b20a1e314924e5396c0110729210109/544383ced8934545a4b92896a7ffeef1.jpg, createdBy=b6715568846, createdName=Iam雨后彩虹, createdTime=Fri Feb 17 16:10:56 CST 2023, time=2023-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179873, encodeId=1f3611e9873a8, content=请问一下各位大佬,该杂志需要版面费吗,case report and review接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ca66444402, createdName=ms5000001652603950, createdTime=Sun Jan 02 22:47:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501260, encodeId=93da50126070, content=请问楼下的这个杂志在线投稿时,第4项是推荐reviewer,而且还是必须要填的,不然无法成功投稿,从哪里能找到他们的reviewer啊?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 21 23:01:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105791, encodeId=1a3d2105e9156, content=请问首次投稿的时候就得把原始数据放在共享数据库里吗,能不能等看看会不会直接拒稿再进行下一步共享数据?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Dec 12 21:53:04 CST 2022, time=2022-12-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210105, encodeId=f67c12101054d, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:内分泌<br>经验分享:不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29b1939503, createdName=Wittyone, createdTime=Sun Apr 10 19:28:15 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559798, encodeId=50cf559e9840, content=Under review 下一个是什么 大概多久呀<span class="quote">151****6521暂无昵称 2018-06-04 发表::<br>投稿第二天就Under review了,听说这个杂志没有with editor这个状态</span><span class="quote">151****6521暂无昵称 2018-06-04 13:56:00 发表:<br>投稿第二天就Under review了,听说这个杂志没有with editor这个状态</span>, beContent=151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了,听说这个杂志没有with editor这个状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e2398662, createdName=1234c804m77暂无昵称, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581170, encodeId=a8b45811e0f9, content=都说不收糖尿病的了<span class="quote">hpchensd 2019-11-21 00:00:00 发表:<br>啥原因?我也想投一篇糖尿病高血压的</span>, beContent=hpchensd 2019-11-21 00:00:00 发表: 啥原因?我也想投一篇糖尿病高血压的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/01/768c3273b4a500f3bc36c611fc31585d.jpg, createdBy=3f032574018, createdName=Allianst, createdTime=Mon Dec 09 00:00:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052346, encodeId=4b6c10523465b, content=偏重的研究方向:内分泌<br>经验分享:2021.09.16投稿,2021.09.17让修稿,但是审稿意见就说了下如果是随机对照实验的话,请遵循对照原则(我的不是),然后提了下文章格式让弄成双倍间隔,就没有了。感觉好危险,这怎么修啊,你们的会给你发修改稿吗,上面会标注细节的那种?第一次投稿的小白,希望同道回答下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Fri Sep 17 16:29:14 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198382, encodeId=8573119838230, content=这杂志对国人友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc31688675, createdName=Labmed 9954, createdTime=Tue Mar 01 15:16:11 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088823, encodeId=54391088823f6, content=如何查找特定期刊要求的格式?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-12-12 ms7000001469871773 来自山东省

    请问首次投稿的时候就得把原始数据放在共享数据库里吗,能不能等看看会不会直接拒稿再进行下一步共享数据?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2115113, encodeId=ceb92115113fa, content=投稿两个多月了,现在还是Under Review,催了一次编辑说是还在找审稿人,审稿有点慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/2b20a1e314924e5396c0110729210109/544383ced8934545a4b92896a7ffeef1.jpg, createdBy=b6715568846, createdName=Iam雨后彩虹, createdTime=Fri Feb 17 16:10:56 CST 2023, time=2023-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179873, encodeId=1f3611e9873a8, content=请问一下各位大佬,该杂志需要版面费吗,case report and review接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ca66444402, createdName=ms5000001652603950, createdTime=Sun Jan 02 22:47:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501260, encodeId=93da50126070, content=请问楼下的这个杂志在线投稿时,第4项是推荐reviewer,而且还是必须要填的,不然无法成功投稿,从哪里能找到他们的reviewer啊?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 21 23:01:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105791, encodeId=1a3d2105e9156, content=请问首次投稿的时候就得把原始数据放在共享数据库里吗,能不能等看看会不会直接拒稿再进行下一步共享数据?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Dec 12 21:53:04 CST 2022, time=2022-12-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210105, encodeId=f67c12101054d, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:内分泌<br>经验分享:不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29b1939503, createdName=Wittyone, createdTime=Sun Apr 10 19:28:15 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559798, encodeId=50cf559e9840, content=Under review 下一个是什么 大概多久呀<span class="quote">151****6521暂无昵称 2018-06-04 发表::<br>投稿第二天就Under review了,听说这个杂志没有with editor这个状态</span><span class="quote">151****6521暂无昵称 2018-06-04 13:56:00 发表:<br>投稿第二天就Under review了,听说这个杂志没有with editor这个状态</span>, beContent=151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了,听说这个杂志没有with editor这个状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e2398662, createdName=1234c804m77暂无昵称, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581170, encodeId=a8b45811e0f9, content=都说不收糖尿病的了<span class="quote">hpchensd 2019-11-21 00:00:00 发表:<br>啥原因?我也想投一篇糖尿病高血压的</span>, beContent=hpchensd 2019-11-21 00:00:00 发表: 啥原因?我也想投一篇糖尿病高血压的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/01/768c3273b4a500f3bc36c611fc31585d.jpg, createdBy=3f032574018, createdName=Allianst, createdTime=Mon Dec 09 00:00:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052346, encodeId=4b6c10523465b, content=偏重的研究方向:内分泌<br>经验分享:2021.09.16投稿,2021.09.17让修稿,但是审稿意见就说了下如果是随机对照实验的话,请遵循对照原则(我的不是),然后提了下文章格式让弄成双倍间隔,就没有了。感觉好危险,这怎么修啊,你们的会给你发修改稿吗,上面会标注细节的那种?第一次投稿的小白,希望同道回答下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Fri Sep 17 16:29:14 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198382, encodeId=8573119838230, content=这杂志对国人友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc31688675, createdName=Labmed 9954, createdTime=Tue Mar 01 15:16:11 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088823, encodeId=54391088823f6, content=如何查找特定期刊要求的格式?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-04-10 Wittyone

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:内分泌
    经验分享:不错的杂志

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2115113, encodeId=ceb92115113fa, content=投稿两个多月了,现在还是Under Review,催了一次编辑说是还在找审稿人,审稿有点慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/2b20a1e314924e5396c0110729210109/544383ced8934545a4b92896a7ffeef1.jpg, createdBy=b6715568846, createdName=Iam雨后彩虹, createdTime=Fri Feb 17 16:10:56 CST 2023, time=2023-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179873, encodeId=1f3611e9873a8, content=请问一下各位大佬,该杂志需要版面费吗,case report and review接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ca66444402, createdName=ms5000001652603950, createdTime=Sun Jan 02 22:47:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501260, encodeId=93da50126070, content=请问楼下的这个杂志在线投稿时,第4项是推荐reviewer,而且还是必须要填的,不然无法成功投稿,从哪里能找到他们的reviewer啊?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 21 23:01:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105791, encodeId=1a3d2105e9156, content=请问首次投稿的时候就得把原始数据放在共享数据库里吗,能不能等看看会不会直接拒稿再进行下一步共享数据?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Dec 12 21:53:04 CST 2022, time=2022-12-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210105, encodeId=f67c12101054d, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:内分泌<br>经验分享:不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29b1939503, createdName=Wittyone, createdTime=Sun Apr 10 19:28:15 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559798, encodeId=50cf559e9840, content=Under review 下一个是什么 大概多久呀<span class="quote">151****6521暂无昵称 2018-06-04 发表::<br>投稿第二天就Under review了,听说这个杂志没有with editor这个状态</span><span class="quote">151****6521暂无昵称 2018-06-04 13:56:00 发表:<br>投稿第二天就Under review了,听说这个杂志没有with editor这个状态</span>, beContent=151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了,听说这个杂志没有with editor这个状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e2398662, createdName=1234c804m77暂无昵称, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581170, encodeId=a8b45811e0f9, content=都说不收糖尿病的了<span class="quote">hpchensd 2019-11-21 00:00:00 发表:<br>啥原因?我也想投一篇糖尿病高血压的</span>, beContent=hpchensd 2019-11-21 00:00:00 发表: 啥原因?我也想投一篇糖尿病高血压的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/01/768c3273b4a500f3bc36c611fc31585d.jpg, createdBy=3f032574018, createdName=Allianst, createdTime=Mon Dec 09 00:00:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052346, encodeId=4b6c10523465b, content=偏重的研究方向:内分泌<br>经验分享:2021.09.16投稿,2021.09.17让修稿,但是审稿意见就说了下如果是随机对照实验的话,请遵循对照原则(我的不是),然后提了下文章格式让弄成双倍间隔,就没有了。感觉好危险,这怎么修啊,你们的会给你发修改稿吗,上面会标注细节的那种?第一次投稿的小白,希望同道回答下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Fri Sep 17 16:29:14 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198382, encodeId=8573119838230, content=这杂志对国人友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc31688675, createdName=Labmed 9954, createdTime=Tue Mar 01 15:16:11 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088823, encodeId=54391088823f6, content=如何查找特定期刊要求的格式?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2018-08-03 1234c804m77暂无昵称

    Under review 下一个是什么 大概多久呀151****6521暂无昵称 2018-06-04 发表::
    投稿第二天就Under review了,听说这个杂志没有with editor这个状态
    151****6521暂无昵称 2018-06-04 13:56:00 发表:
    投稿第二天就Under review了,听说这个杂志没有with editor这个状态

    151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了,听说这个杂志没有with editor这个状态

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2115113, encodeId=ceb92115113fa, content=投稿两个多月了,现在还是Under Review,催了一次编辑说是还在找审稿人,审稿有点慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/2b20a1e314924e5396c0110729210109/544383ced8934545a4b92896a7ffeef1.jpg, createdBy=b6715568846, createdName=Iam雨后彩虹, createdTime=Fri Feb 17 16:10:56 CST 2023, time=2023-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179873, encodeId=1f3611e9873a8, content=请问一下各位大佬,该杂志需要版面费吗,case report and review接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ca66444402, createdName=ms5000001652603950, createdTime=Sun Jan 02 22:47:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501260, encodeId=93da50126070, content=请问楼下的这个杂志在线投稿时,第4项是推荐reviewer,而且还是必须要填的,不然无法成功投稿,从哪里能找到他们的reviewer啊?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 21 23:01:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105791, encodeId=1a3d2105e9156, content=请问首次投稿的时候就得把原始数据放在共享数据库里吗,能不能等看看会不会直接拒稿再进行下一步共享数据?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Dec 12 21:53:04 CST 2022, time=2022-12-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210105, encodeId=f67c12101054d, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:内分泌<br>经验分享:不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29b1939503, createdName=Wittyone, createdTime=Sun Apr 10 19:28:15 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559798, encodeId=50cf559e9840, content=Under review 下一个是什么 大概多久呀<span class="quote">151****6521暂无昵称 2018-06-04 发表::<br>投稿第二天就Under review了,听说这个杂志没有with editor这个状态</span><span class="quote">151****6521暂无昵称 2018-06-04 13:56:00 发表:<br>投稿第二天就Under review了,听说这个杂志没有with editor这个状态</span>, beContent=151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了,听说这个杂志没有with editor这个状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e2398662, createdName=1234c804m77暂无昵称, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581170, encodeId=a8b45811e0f9, content=都说不收糖尿病的了<span class="quote">hpchensd 2019-11-21 00:00:00 发表:<br>啥原因?我也想投一篇糖尿病高血压的</span>, beContent=hpchensd 2019-11-21 00:00:00 发表: 啥原因?我也想投一篇糖尿病高血压的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/01/768c3273b4a500f3bc36c611fc31585d.jpg, createdBy=3f032574018, createdName=Allianst, createdTime=Mon Dec 09 00:00:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052346, encodeId=4b6c10523465b, content=偏重的研究方向:内分泌<br>经验分享:2021.09.16投稿,2021.09.17让修稿,但是审稿意见就说了下如果是随机对照实验的话,请遵循对照原则(我的不是),然后提了下文章格式让弄成双倍间隔,就没有了。感觉好危险,这怎么修啊,你们的会给你发修改稿吗,上面会标注细节的那种?第一次投稿的小白,希望同道回答下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Fri Sep 17 16:29:14 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198382, encodeId=8573119838230, content=这杂志对国人友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc31688675, createdName=Labmed 9954, createdTime=Tue Mar 01 15:16:11 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088823, encodeId=54391088823f6, content=如何查找特定期刊要求的格式?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2019-12-09 Allianst

    都说不收糖尿病的了hpchensd 2019-11-21 00:00:00 发表:
    啥原因?我也想投一篇糖尿病高血压的

    hpchensd 2019-11-21 00:00:00 发表: 啥原因?我也想投一篇糖尿病高血压的

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2115113, encodeId=ceb92115113fa, content=投稿两个多月了,现在还是Under Review,催了一次编辑说是还在找审稿人,审稿有点慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/2b20a1e314924e5396c0110729210109/544383ced8934545a4b92896a7ffeef1.jpg, createdBy=b6715568846, createdName=Iam雨后彩虹, createdTime=Fri Feb 17 16:10:56 CST 2023, time=2023-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179873, encodeId=1f3611e9873a8, content=请问一下各位大佬,该杂志需要版面费吗,case report and review接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ca66444402, createdName=ms5000001652603950, createdTime=Sun Jan 02 22:47:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501260, encodeId=93da50126070, content=请问楼下的这个杂志在线投稿时,第4项是推荐reviewer,而且还是必须要填的,不然无法成功投稿,从哪里能找到他们的reviewer啊?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 21 23:01:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105791, encodeId=1a3d2105e9156, content=请问首次投稿的时候就得把原始数据放在共享数据库里吗,能不能等看看会不会直接拒稿再进行下一步共享数据?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Dec 12 21:53:04 CST 2022, time=2022-12-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210105, encodeId=f67c12101054d, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:内分泌<br>经验分享:不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29b1939503, createdName=Wittyone, createdTime=Sun Apr 10 19:28:15 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559798, encodeId=50cf559e9840, content=Under review 下一个是什么 大概多久呀<span class="quote">151****6521暂无昵称 2018-06-04 发表::<br>投稿第二天就Under review了,听说这个杂志没有with editor这个状态</span><span class="quote">151****6521暂无昵称 2018-06-04 13:56:00 发表:<br>投稿第二天就Under review了,听说这个杂志没有with editor这个状态</span>, beContent=151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了,听说这个杂志没有with editor这个状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e2398662, createdName=1234c804m77暂无昵称, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581170, encodeId=a8b45811e0f9, content=都说不收糖尿病的了<span class="quote">hpchensd 2019-11-21 00:00:00 发表:<br>啥原因?我也想投一篇糖尿病高血压的</span>, beContent=hpchensd 2019-11-21 00:00:00 发表: 啥原因?我也想投一篇糖尿病高血压的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/01/768c3273b4a500f3bc36c611fc31585d.jpg, createdBy=3f032574018, createdName=Allianst, createdTime=Mon Dec 09 00:00:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052346, encodeId=4b6c10523465b, content=偏重的研究方向:内分泌<br>经验分享:2021.09.16投稿,2021.09.17让修稿,但是审稿意见就说了下如果是随机对照实验的话,请遵循对照原则(我的不是),然后提了下文章格式让弄成双倍间隔,就没有了。感觉好危险,这怎么修啊,你们的会给你发修改稿吗,上面会标注细节的那种?第一次投稿的小白,希望同道回答下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Fri Sep 17 16:29:14 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198382, encodeId=8573119838230, content=这杂志对国人友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc31688675, createdName=Labmed 9954, createdTime=Tue Mar 01 15:16:11 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088823, encodeId=54391088823f6, content=如何查找特定期刊要求的格式?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-09-17 ms9000001057878125

    偏重的研究方向:内分泌
    经验分享:2021.09.16投稿,2021.09.17让修稿,但是审稿意见就说了下如果是随机对照实验的话,请遵循对照原则(我的不是),然后提了下文章格式让弄成双倍间隔,就没有了。感觉好危险,这怎么修啊,你们的会给你发修改稿吗,上面会标注细节的那种?第一次投稿的小白,希望同道回答下。

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2115113, encodeId=ceb92115113fa, content=投稿两个多月了,现在还是Under Review,催了一次编辑说是还在找审稿人,审稿有点慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/2b20a1e314924e5396c0110729210109/544383ced8934545a4b92896a7ffeef1.jpg, createdBy=b6715568846, createdName=Iam雨后彩虹, createdTime=Fri Feb 17 16:10:56 CST 2023, time=2023-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179873, encodeId=1f3611e9873a8, content=请问一下各位大佬,该杂志需要版面费吗,case report and review接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ca66444402, createdName=ms5000001652603950, createdTime=Sun Jan 02 22:47:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501260, encodeId=93da50126070, content=请问楼下的这个杂志在线投稿时,第4项是推荐reviewer,而且还是必须要填的,不然无法成功投稿,从哪里能找到他们的reviewer啊?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 21 23:01:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105791, encodeId=1a3d2105e9156, content=请问首次投稿的时候就得把原始数据放在共享数据库里吗,能不能等看看会不会直接拒稿再进行下一步共享数据?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Dec 12 21:53:04 CST 2022, time=2022-12-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210105, encodeId=f67c12101054d, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:内分泌<br>经验分享:不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29b1939503, createdName=Wittyone, createdTime=Sun Apr 10 19:28:15 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559798, encodeId=50cf559e9840, content=Under review 下一个是什么 大概多久呀<span class="quote">151****6521暂无昵称 2018-06-04 发表::<br>投稿第二天就Under review了,听说这个杂志没有with editor这个状态</span><span class="quote">151****6521暂无昵称 2018-06-04 13:56:00 发表:<br>投稿第二天就Under review了,听说这个杂志没有with editor这个状态</span>, beContent=151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了,听说这个杂志没有with editor这个状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e2398662, createdName=1234c804m77暂无昵称, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581170, encodeId=a8b45811e0f9, content=都说不收糖尿病的了<span class="quote">hpchensd 2019-11-21 00:00:00 发表:<br>啥原因?我也想投一篇糖尿病高血压的</span>, beContent=hpchensd 2019-11-21 00:00:00 发表: 啥原因?我也想投一篇糖尿病高血压的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/01/768c3273b4a500f3bc36c611fc31585d.jpg, createdBy=3f032574018, createdName=Allianst, createdTime=Mon Dec 09 00:00:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052346, encodeId=4b6c10523465b, content=偏重的研究方向:内分泌<br>经验分享:2021.09.16投稿,2021.09.17让修稿,但是审稿意见就说了下如果是随机对照实验的话,请遵循对照原则(我的不是),然后提了下文章格式让弄成双倍间隔,就没有了。感觉好危险,这怎么修啊,你们的会给你发修改稿吗,上面会标注细节的那种?第一次投稿的小白,希望同道回答下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Fri Sep 17 16:29:14 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198382, encodeId=8573119838230, content=这杂志对国人友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc31688675, createdName=Labmed 9954, createdTime=Tue Mar 01 15:16:11 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088823, encodeId=54391088823f6, content=如何查找特定期刊要求的格式?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-03-01 Labmed 9954

    这杂志对国人友好吗

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2115113, encodeId=ceb92115113fa, content=投稿两个多月了,现在还是Under Review,催了一次编辑说是还在找审稿人,审稿有点慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210810/2b20a1e314924e5396c0110729210109/544383ced8934545a4b92896a7ffeef1.jpg, createdBy=b6715568846, createdName=Iam雨后彩虹, createdTime=Fri Feb 17 16:10:56 CST 2023, time=2023-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179873, encodeId=1f3611e9873a8, content=请问一下各位大佬,该杂志需要版面费吗,case report and review接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ca66444402, createdName=ms5000001652603950, createdTime=Sun Jan 02 22:47:21 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501260, encodeId=93da50126070, content=请问楼下的这个杂志在线投稿时,第4项是推荐reviewer,而且还是必须要填的,不然无法成功投稿,从哪里能找到他们的reviewer啊?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 21 23:01:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105791, encodeId=1a3d2105e9156, content=请问首次投稿的时候就得把原始数据放在共享数据库里吗,能不能等看看会不会直接拒稿再进行下一步共享数据?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e88440897, createdName=ms7000001469871773, createdTime=Mon Dec 12 21:53:04 CST 2022, time=2022-12-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1210105, encodeId=f67c12101054d, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:内分泌<br>经验分享:不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29b1939503, createdName=Wittyone, createdTime=Sun Apr 10 19:28:15 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559798, encodeId=50cf559e9840, content=Under review 下一个是什么 大概多久呀<span class="quote">151****6521暂无昵称 2018-06-04 发表::<br>投稿第二天就Under review了,听说这个杂志没有with editor这个状态</span><span class="quote">151****6521暂无昵称 2018-06-04 13:56:00 发表:<br>投稿第二天就Under review了,听说这个杂志没有with editor这个状态</span>, beContent=151****6521暂无昵称 2018-06-04 发表:: 投稿第二天就Under review了,听说这个杂志没有with editor这个状态, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e2398662, createdName=1234c804m77暂无昵称, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581170, encodeId=a8b45811e0f9, content=都说不收糖尿病的了<span class="quote">hpchensd 2019-11-21 00:00:00 发表:<br>啥原因?我也想投一篇糖尿病高血压的</span>, beContent=hpchensd 2019-11-21 00:00:00 发表: 啥原因?我也想投一篇糖尿病高血压的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/01/768c3273b4a500f3bc36c611fc31585d.jpg, createdBy=3f032574018, createdName=Allianst, createdTime=Mon Dec 09 00:00:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052346, encodeId=4b6c10523465b, content=偏重的研究方向:内分泌<br>经验分享:2021.09.16投稿,2021.09.17让修稿,但是审稿意见就说了下如果是随机对照实验的话,请遵循对照原则(我的不是),然后提了下文章格式让弄成双倍间隔,就没有了。感觉好危险,这怎么修啊,你们的会给你发修改稿吗,上面会标注细节的那种?第一次投稿的小白,希望同道回答下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaec5572087, createdName=ms9000001057878125, createdTime=Fri Sep 17 16:29:14 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198382, encodeId=8573119838230, content=这杂志对国人友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ecc31688675, createdName=Labmed 9954, createdTime=Tue Mar 01 15:16:11 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088823, encodeId=54391088823f6, content=如何查找特定期刊要求的格式?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-12-29 桑晒麦拉

    如何查找特定期刊要求的格式?

    1

    展开1条回复
共90条页码: 1/9页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分